Shire Sues Neos To Block Adderall XR Competitor

By Bill Donahue (April 12, 2013, 3:31 PM EDT) -- Irish biopharmaceutical giant Shire PLC lodged its latest bid Thursday to maintain patent protection over the blockbuster attention deficit hyperactivity disorder treatment Adderall XR, suing Neos Therapeutics Inc. in Texas federal court for applying to produce a competing drug....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!